Combination of Albumin-Bound Paclitaxel and Cisplatin with Radiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma: Results from a Phase II Single-Arm Study - Top-Institutions - MDSpire

Combination of Albumin-Bound Paclitaxel and Cisplatin with Radiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma: Results from a Phase II Single-Arm Study

  • By

  • Shasha Yang

  • Hui Jiang

  • Liang Zhong

  • Kanjiebubi Makelike

  • Baoqing Chen

  • Mian Xi

  • Qiaoqiao Li

  • Yonghong Hu

  • Fanjun Meng

  • Yujia Zhu

  • December 1, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Gastrointestinal Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Medical Oncology
    • Radiation Oncology

  • #3

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Gastrointestinal Oncology

  • #4

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology

Original Source(s)

Combination of Albumin-Bound Paclitaxel and Cisplatin with Radiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma: Results from a Phase II Single-Arm Study

  • by Shasha Yang, Hui Jiang, Liang Zhong, Kanjiebubi Makelike, Baoqing Chen, Mian Xi, Qiaoqiao Li, Yonghong Hu, Fanjun Meng, Yujia Zhu

  • December 1, 2025

Related Content

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study

A predictive nomogram for elderly individuals with unresectable esophageal cancer receiving intensity-modulated radiotherapy

Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma